Results 131 to 140 of about 40,209 (324)

Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR‐SCREEN‐2 Study

open access: yesCancer Science, EarlyView.
ABSTRACT Claudin 18.2 (CLDN18.2), a tight junction protein isoform, is an emerging therapeutic target in oncology. CLDN18 is well‐characterized in gastric cancer, but its pan‐cancer expression profiles and isoform distributions are poorly documented.
Tadayoshi Hashimoto   +28 more
wiley   +1 more source

The Pediatric Screening–Priority Evaluation Dysphagia: Validation of a new tool for screening swallowing disorders in infants and children

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
The Pediatric Screening‐Priority Evaluation Dysphagia (PS‐PED) is a novel, non‐invasive, 14‐item screening tool designed to identify swallowing disorders in children. It encompasses three key domains: clinical history, health status, and feeding condition.
Antonella Cerchiari   +8 more
wiley   +1 more source

Peroral endoscopic myotomy as a treatment for Killian–Jamieson diverticulum (KJ-POEM)

open access: yesEndoscopy International Open
Redeat Libanos Assefa   +18 more
doaj   +1 more source

Histopathological spectrum of lesions of upper gastrointestinal tract – A study of endoscopic biopsies

open access: yesGlobal Journal of Medicine and Public Health
Background The disorders of upper gastrointestinal tract are responsible for a great deal of morbidity and mortality. Upper GI endoscopy in combination with biopsy plays an important role in the exact diagnosis of these disorders for further
Bilal A Sheikh   +2 more
doaj  

Effectiveness and safety of antithrombin for treatment of portal vein thrombosis: Nationwide prospective surveillance of 4 years of clinical experience in Japan

open access: yesHepatology Research, EarlyView.
Abstract Aim Antithrombin (AT), a plasma protein with anticoagulant properties, has a long‐standing medical history, primarily for treatment of congenital AT deficiency. Accumulated clinical experiences suggest AT is a potential anticoagulant for thrombotic diseases. This study aimed to clarify the effectiveness, safety, and clinical significance of AT
Shoichi Matsutani   +2 more
wiley   +1 more source

Serum proteomic and metabolomic analyses from patients with IBD identify biological pathways associated with treatment success with anti‐integrin therapy

open access: yesImmunology &Cell Biology, EarlyView.
In this article, we have analyzed the serum proteome and metabolome in inflammatory bowel disease patients being treated with the anti‐α4β7 integrin therapeutic agent vedolizumab. The pretreatment biomarker profiles, as well as changes in biomarker profiles during treatment, identified likely pro‐inflammatory pathways associated with treatment response.
John D Rioux   +30 more
wiley   +1 more source

Endoscopic transoral outlet reduction induces enterohormonal changes in patients with weight regain after Roux-en-Y gastric bypass

open access: yesEndoscopy International Open
Vitor Ottoboni Brunaldi   +8 more
doaj   +1 more source

Usefulness of Endoscopic Mucosal Resection Using an Over‐the‐Scope Clip for Duodenal Neuroendocrine Tumors: A Multicenter Retrospective Comparative Study

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim Resection of non‐ampullary duodenal neuroendocrine tumors presents technical challenges. This study investigated the efficacy and safety of endoscopic mucosal resection using an over‐the‐scope clip compared to endoscopic mucosal resection with a ligation device and endoscopic submucosal dissection. Methods This retrospective
Tomoaki Tashima   +11 more
wiley   +1 more source

Pilot evaluation of a novel, automated ergonomics assessment tool

open access: yesEndoscopy International Open
Bara El Kurdi   +11 more
doaj   +1 more source

Endoscopic insights into digestive-related adverse effects of immune checkpoint inhibitors: A narrative review. [PDF]

open access: yesWorld J Gastrointest Endosc
Petrousis G   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy